Antagonist

Results: 956



#Item
361Microsoft Word - GPupdate6.doc

Microsoft Word - GPupdate6.doc

Add to Reading List

Source URL: www.hbprca.com.au

Language: English - Date: 2010-09-22 02:24:53
362TRACLEER® [bosentan[removed]mg and 125 mg film-coated tablets Use of TRACLEER® requires attention to two significant concerns: 1) potential for serious liver injury and 2) potential damage to a fetus.

TRACLEER® [bosentan[removed]mg and 125 mg film-coated tablets Use of TRACLEER® requires attention to two significant concerns: 1) potential for serious liver injury and 2) potential damage to a fetus.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:51:02
3633  patient characteristics One sweeps by, attended by an immense train, All emblematic of peace – not a soldier or menial

3 patient characteristics One sweeps by, attended by an immense train, All emblematic of peace – not a soldier or menial

Add to Reading List

Source URL: www.usrds.org

Language: English - Date: 2005-10-13 15:29:58
364This presentation contains preliminary data that is subject to change due to additional experimental data or data analysis. It does not represent Agency endorsement or policy.  Do not cite or quote

This presentation contains preliminary data that is subject to change due to additional experimental data or data analysis. It does not represent Agency endorsement or policy. Do not cite or quote

Add to Reading List

Source URL: epa.gov

Language: English - Date: 2013-04-10 16:29:26
365Combining Pathway-Based In Vitro Assays to Prioritize 1848 Environmental Chemicals for Estrogenic Potential D Rotroff1,2, D Reif1, N Sipes1, T Knudsen1, P Kothiya1, M Martin1, K Houck1, R Judson1 1 National Center for Co

Combining Pathway-Based In Vitro Assays to Prioritize 1848 Environmental Chemicals for Estrogenic Potential D Rotroff1,2, D Reif1, N Sipes1, T Knudsen1, P Kothiya1, M Martin1, K Houck1, R Judson1 1 National Center for Co

Add to Reading List

Source URL: epa.gov

Language: English - Date: 2013-04-10 16:29:09
366CHECK IN TIME: ______________ ALLERGY TESTING If you arrive late, your appointment may be cancelled.

CHECK IN TIME: ______________ ALLERGY TESTING If you arrive late, your appointment may be cancelled.

Add to Reading List

Source URL: www.minorandjames.com

Language: English - Date: 2014-04-23 15:54:58
367Intra-articular Administration of a Recombinant Adeno-Associated Vector containing a  TNF-a Antagonist Gene in Inflammatory Arthritis

Intra-articular Administration of a Recombinant Adeno-Associated Vector containing a TNF-a Antagonist Gene in Inflammatory Arthritis

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-09 11:14:34
368Collaborative Drug Therapy Agreement for Naloxone Medication in Overdose Prevention

Collaborative Drug Therapy Agreement for Naloxone Medication in Overdose Prevention

Add to Reading List

Source URL: stopoverdose.org

Language: English - Date: 2013-01-22 18:40:45
369CINV RISK ASSESSMENT If you are starting chemotherapy, you could be at risk for chemotherapy-induced nausea and vomiting (CINV). You may want to understand your risk before beginning chemotherapy and discuss CINV with yo

CINV RISK ASSESSMENT If you are starting chemotherapy, you could be at risk for chemotherapy-induced nausea and vomiting (CINV). You may want to understand your risk before beginning chemotherapy and discuss CINV with yo

Add to Reading List

Source URL: www.aloxi.com

Language: English - Date: 2014-07-24 11:17:30
370FDA Briefing Document for the Cardiovascular and Renal Drugs Advisory (CRDAC) Meeting Date:  13 September 2012

FDA Briefing Document for the Cardiovascular and Renal Drugs Advisory (CRDAC) Meeting Date: 13 September 2012

Add to Reading List

Source URL: www.fda.gov

Language: English